NCT06806644View on ClinicalTrials.gov

The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Nephropathy
Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06806644 - The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy | Biotech Hunter | Biotech Hunter